FDA approves new menopause drug without hormones. Here’s what to know.
The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a…
2025 Houston Innovation Awards finalists: Health-tech Business
Home to leading hospitals, universities and health-focused incubators, Houston is a breeding ground for innovative medical technology and…
New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of Color
Is an Alzheimer’s clinical trial right for you? What does it mean to enroll in an Alzheimer’s clinical…
Allergic Rhino-Conjunctivitis Market Poised for Significant Growth in the Coming 10 Years Amid Increasing Therapeutic Advancements
The allergic rhino-conjunctivitis market is experiencing steady growth, driven by the rising prevalence of allergic conditions and increased…
Common opioid is not that effective for easing chronic pain, study finds
Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new…
Tip Sheet: Expert insights into full-body MRIs and multi-cancer detection tests, breastmilk antibodies — and progress in AI for cancer research
SEATTLE — Oct. 7, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
A Gene Therapy ‘First’: Huntington’s Disease Successfully Treated in Early Trial
In an hours-long brain surgery, doctors delivered a new piece of genetic code directly into patients’ brains. Early…
FDA rejects Rexulti-Zoloft combo for PTSD
The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…
Enteromix, Russia’s cancer vaccine achieves 100% efficacy in clinical trials
In what could be a miracle improving and saving thousands of lives across the globe, Russia’s mRNA-based vaccine…
Rivaroxaban or Combo Therapy: A Winner for All Ages? – Medscape
Rivaroxaban or Combo Therapy: A Winner for All Ages? Medscape Rivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary…